Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metamizole for Pain in Chronic Pancreatitis
2023-504143-14-00Phase 4Authorised
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic pancreatitis (CP) comparing Dolamizol (metamizole) arm with Placebo arm (2 arms). Primary endpoint: Mean daily pain intensity score. Planned start Oct 2023; status: authorised.
02
Drugs
doxepin + metamizole
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2023-504143-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504143-14-00.